← Leaderboards
Michael S Donnenberg
University Of Maryland Baltimore
$13,045,909
Attributed
$13,122,369
Total exposure
16
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,122,369 · 16
By mechanism
R01$6,444,111 · 3
U19$1,768,534 · 1
T32$1,742,099 · 2
R21$1,622,864 · 4
R56$830,210 · 2
R03$454,921 · 3
Top collaborators
- Montserrat Samso2 shared
Others in their field
Top investigators on “Escherichia Coli”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Scott J Hultgren · Washington University$41,419,179
- John L Markley · University Of Wisconsin Madison$37,032,573
- Wilhelmus G. J. Hol · University Of Washington$31,124,692
- Vanessa Sperandio · University Of Wisconsin-Madison$27,468,669
- Peter D Karp · Sri International$27,278,650
Research focus
Escherichia ColiProteinsEnteropathogenic Escherichia ColiBacteriaPathogenesisVirulenceMembraneLeadBacterial GeneticsComplexResearch StudyCellsInfectionSurfacePilumBacterial ProteinsDiarrheaStructurePathogenPreventCessation Of LifeInfantFimbriae ProteinsVirulence Factors
Grant awards (59)
Enzymology and Structure of Divergent Type 4 Pilus Extension ATPases$75,296
R03 · FY2025 · AI · contact PI
VCU Medical Scientist Training Program$287,814
T32 · FY2024 · GM · contact PI
Enzymology and Structure of Divergent Type 4 Pilus Extension ATPases$77,625
R03 · FY2024 · AI · contact PI
VCU Medical Scientist Training Program$276,519
T32 · FY2023 · GM · contact PI
VCU NIGMS Mentoring supplement$85,672
T32 · FY2023 · GM · contact PI
VCU Medical Scientist Training Program$135,211
T32 · FY2022 · GM · contact PI
Secretin Architecture$191,875
R21 · FY2017 · AI · contact PI
Secretin Architecture$170,426
R21 · FY2016 · AI · contact PI
Novel antimicrobials targeting type IV pilus and type 2 secretion systems$164,392
R21 · FY2016 · AI · contact PI
Secretin Architecture$68,699
R21 · FY2016 · AI · contact PI
Novel antimicrobials targeting type IV pilus and type 2 secretion systems$45,674
R21 · FY2016 · AI · contact PI
Progress In Understanding Type IV Pilus Biogenesis$455,210
R56 · FY2015 · AI · contact PI
Medical Scientist Training Program$404,909
T32 · FY2015 · GM · contact PI
Novel antimicrobials targeting type IV pilus and type 2 secretion systems$209,911
R21 · FY2015 · AI · contact PI
Pathogenesis$342,607
U19 · FY2014 · AI · contact PI
Structure and Role in Disease of Clostridium difficile Type IV Pili$189,303
R21 · FY2014 · AI · contact PI
Medical Scientist Training Program$184,954
T32 · FY2014 · GM · contact PI
Pathogenesis$298,400
U19 · FY2013 · AI · contact PI
Structure and Role in Disease of Clostridium difficile Type IV Pili$232,740
R21 · FY2013 · AI · contact PI
Medical Scientist Training Program$183,510
T32 · FY2013 · GM · contact PI
Vaccine Potential of Type IV Pilin from Clostridium difficle$76,750
R03 · FY2013 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E. coli$367,538
R01 · FY2012 · AI · contact PI
Pathogenesis$296,082
U19 · FY2012 · AI · contact PI
Medical Scientist Training Program$183,510
T32 · FY2012 · GM · contact PI
Vaccine Potential of Type IV Pilin from Clostridium difficle$76,750
R03 · FY2012 · AI · contact PI
Pathogenesis$387,950
U19 · FY2011 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E. coli$367,538
R01 · FY2011 · AI · contact PI
Pathogenesis$443,495
U19 · FY2010 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E. coli$371,250
R01 · FY2010 · AI · contact PI
Escherichia coli and Colorectal Carcinogenesis$165,000
R21 · FY2010 · CA · contact PI
The eae Gene Cluster of Enteropathogenic E. coli$375,000
R01 · FY2009 · AI · contact PI
Molecular Basis of Localized Adherence in E. coli$274,603
R01 · FY2009 · AI · contact PI
Escherichia coli and Colorectal Carcinogenesis$184,844
R21 · FY2009 · CA · contact PI
Molecular Basis of Localized Adherence in E. coli$276,259
R01 · FY2008 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E. coli$250,001
R01 · FY2008 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E.coli$375,000
R56 · FY2007 · AI · contact PI
Molecular Basis of Localized Adherence in E. coli$281,609
R01 · FY2007 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E.coli$290,021
R01 · FY2006 · AI · contact PI
Molecular Basis of Localized Adherence in E. coli$290,021
R01 · FY2006 · AI · contact PI
The eae Gene Cluster of Enteropathogenic E.coli$297,000
R01 · FY2005 · AI
Molecular Basis of Localized Adherence in E. coli$282,450
R01 · FY2005 · AI
The eae Gene Cluster of Enteropathogenic E.coli$297,000
R01 · FY2004 · AI
MOLECULAR BASIS OF LOCALIZED ADHERENCE IN E. COLI$222,750
R01 · FY2004 · AI
Type IV Pilins as Vaccines against Bioterrorism Threats$74,250
R03 · FY2004 · AI
The eae Gene Cluster of Enteropathogenic E.coli$297,000
R01 · FY2003 · AI
MOLECULAR BASIS OF LOCALIZED ADHERENCE IN E. COLI$222,750
R01 · FY2003 · AI
Type IV Pilins as Vaccines against Bioterrorism Threats$74,250
R03 · FY2003 · AI
The eae Gene Cluster of Enteropathogenic E.coli$297,000
R01 · FY2002 · AI
MOLECULAR BASIS OF LOCALIZED ADHERENCE IN E. COLI$222,750
R01 · FY2002 · AI
UROPATHOGENIC E COLI VIRULENCE GENES--COMPREHENSIVE ANALYSIS$0
P01 · FY2002 · DK
UROPATHOGENIC E COLI VIRULENCE GENES--COMPREHENSIVE ANALYSIS$0
P01 · FY2002 · DK
EAE GENE CLUSTER OF ENTEROPATHOGENIC E COLI$241,966
R01 · FY2001 · AI
MOLECULAR BASIS OF LOCALIZED ADHERENCE IN E. COLI$222,750
R01 · FY2001 · AI
UROPATHOGENIC E COLI VIRULENCE GENES--COMPREHENSIVE ANALYSIS$129,815
P01 · FY2001 · DK
UROPATHOGENIC E COLI VIRULENCE GENES--COMPREHENSIVE ANALYSIS$0
P01 · FY2001 · DK
IMMUNOREGULATORY BACTERIAL FACTORS IN ULCERATIVE COLITIS$239,186
R01 · FY2000 · DK
EAE GENE CLUSTER OF ENTEROPATHOGENIC E COLI$234,919
R01 · FY2000 · AI
MOLECULAR BASIS OF LOCALIZED ADHERENCE IN E. COLI$222,750
R01 · FY2000 · AI
UROPATHOGENIC E COLI VIRULENCE GENES--COMPREHENSIVE ANALYSIS$129,815
P01 · FY2000 · DK